Establishing Transductional Relationships: Viral Vectors as an Experimental Tool in ALS (Amyotrophic Lateral Sclerosis)

Enrique Wulff *

Instituto de Ciencias Marinas de Andalucía (CSIC), Spain.

*Author to whom correspondence should be addressed.


This contribution describes a number of historical aspects of discoveries made in the field of research called signal transduction by analyzing the meaning of the term and its relations to phenomena. Signal transduction refers to any process by which a cell converts one kind of signal or stimulus into another. For instance, that the epigenetic defect may result in additional genetic lesions has been associated with signal transduction pathways. These processes most often involve ordered sequences of biochemical reactions inside the cell, that are carried out by enzymes, and activated by second messengers. Thus suggesting the idea of reversibility at the leading edge of a transduction cascade as the most instrumental value in unveiling the ontology of its downstream elements. The purpose of this essay is to facilitate the historical and philosophical understanding of signaling pathways ultimately designed for the development of novel therapeutic strategies to treat neurological disorders. The repertoire of signal transduction pathways offered by nitric oxide (NO) and the strong ability of viral therapies to liaise effectively with the neurodegenerative sickness progression are researched. In particular, viral therapy research in ALS (amyotrophic lateral sclerosis) as a completely dominated by theory experimentation is taken as an example.

Keywords: ALS (amyotrophic lateral sclerosis), nitric oxide (NO), virotherapy for cancer, theory

How to Cite

Wulff, E. (2023). Establishing Transductional Relationships: Viral Vectors as an Experimental Tool in ALS (Amyotrophic Lateral Sclerosis). UTTAR PRADESH JOURNAL OF ZOOLOGY, 44(1), 22–36.


Download data is not yet available.


Knudson AG. Mutation and cancer: Statistical study of retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America. 1971;68:820-823. Available:

Roe SM, Baumgaertner B. Extended mechanistic explanations: Expanding the current mechanistic conception to include more complex biological systems. Journal for General Philosophy of Science. 2017;48:517–534. Available:

Duran-Reynals F. The reciprocal infection of ducks and chickens with tumor inducing viruses. Cancer Research. 1942;2:343-369.

Kelly E, Russell SJ. History of oncolytic viruses: Genesis to genetic engineering. Molecular Therapy. 2007;15: 651-659. Available:

Wigler M, Silverstein S, Lee LS, Pellicer A, Cheng Y, Axel R. Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell. 1977;11:223-232. Available: 10.1016/0092-8674(77)90333-6

Bechtel W. Generalizing mechanistic explanations using graph-theoretic representations. In: Explanation in Biology. History, Philosophy and Theory of the Life Sciences, Vol. 11. Springer, Dordrecht. 2015;199-225. Available:

Barendregt M, van Hezewijk R. Adaptive and genomic explanations of human behaviour: might evolutionary psychology contribute to behavioural genomics? Biology and Philosophy. 2005;20:57-78. Available:

Brenner S. Turing centenary: Life's code script. Nature. 2012;482:461. Available:

Bertolaso M, Olsson J, Picardi A, Rakela J. Gene therapy and enhancement for diabetes (and other diseases): The multiplicity of considerations. Diabetes/Metabolism Research and Reviews. 2010;26:520-524. Available:

Culp S. Establishing genotype/phenotype relationships: Gene targeting as an experimental approach. Philosophy of Science. 1997;64:S268-S278. Available:

Culotta E, Koshland DE Jr. NO news is good news. Science. 1992;258:1862-1865. Available:

Dillon MC. Merleau-Ponty and the reversibility thesis. Man and World. 1983;16:365-388. Available:

Drechsel DA, Estévez AG, Barbeito L, Beckman JS. Nitric oxide-mediated oxidative damage and the progressive demise of motor neurons in ALS. Neurotoxicity Research. 2012;22:251-264. Available:

Mallon R, Weinberg JM. Innateness as closed process invariance. Philosophy of Science. 2006; 73(3):323-44. Available:

Portillo F, Moreno-López B. Nitric oxide controls excitatory/inhibitory balance in the hypoglossal nucleus during early postnatal development. Brain Structure and Function. 2020;225(9):2871-2884. Available:

Knowles RG, Palacios M, Palmer RM, Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proceedings of the National Academy of Sciences of the United States of America. 1989;86:5159-5162. Available:

Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proceedings of the National Academy of Sciences of the United States of America. 1990;87:682-685. Available:

Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 1991;351:714-718. Available:

Kots AY, Martin E, Sharina IG, Murad F. A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinase. Handbook of Experimental Pharmacology. 2009;191:1-14. Available:

Trias E, Beilby PR, Kovacs M, Ibarburu S, Varela V, Barreto-Núñez R, Bradford SC, Beckman JS, Barbeito L. Emergence of microglia bearing senescence markers during paralysis progression in a rat model of inherited ALS. Frontiers in aging neuroscience.2019;11:42. Available:

Steinert JR, Amal H. The contribution of an imbalanced redox signalling to neurological and neurodegenerative conditions. Free Radical Biology and Medicine. 2023; 194:71-83. Available:

Moncada S. Adventures in vascular biology: A tale of two mediators. Philososophical transactions of the Royal Society of London. Series B, Biological Sciences.2006;361:735-759. Available:

Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell.1993.75:1273-1286. Available:

Steinle F. Entering new fields: Exploratory uses of experimentation. Philosophy of Science.1997;64:S65-S74. Available:

Burian RM. The dilemma of case studies resolved: The virtues of using case studies in the history and philosophy of science. Perspectives on Science. 2001;9:383- 403. Available: 01760375794

Crusio WE. Using spontaneous and induced mutations to dissect brain and behavior genetically. Trends in Neurosciences.1999;22:100-102. Available:

Nelson RJ, Demas GE, Huang PL, Fishman MC, Dawson VL, Dawson TM, Snyder SH. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature. 1995;378:383-386. Available:

Huber L, Keuck LK. Mutant mice: Experimental organisms as materialised models in biomedicine. Studies in History and Philosophy of Biological and Biomedical Sciences. 2013;44:385-391. Available:

Papadopoulos D. The imaginary of plasticity: Neural embodiment, epigenetics and ecomorphs. Sociological Review. 2011;59:432-456. Available:

O'Dell TJ, Huang PL, Dawson TM, Dinerman JL, Snyder SH, Kandel ER, Fishman MC. Endothelial Nos and the blockade of LTP by Nos inhibitors in mice lacking neuronal Nos. Science. 1994;265: 542-546. Available: 10.1126/science.7518615

Meunier R. Stages in the development of a model organism as a platform for mechanistic models in developmental biology: Zebrafish, 1970–2000. Studies in History and Philosophy of Biological and Biomedical Sciences. 2012;43:522-531. Available:

Loeb LA, Springgate CF, Battula N. Errors in DNA replication as a basis of malignant changes. Cancer Research. 1974;34:2311-2321.

Cairns J. Mutation selection and the natural history of cancer. Nature. 1975; 255:197-200. Available:

de Chadarevian S. Mapping development or how molecular is molecular biology? History and Philosophy of the Life Sciences. 2000;22:381-396. Available:

Bechtel W, Richardson RC. Discovering complexity: decomposition and localization as strategies in scientific research. The MIT Press, Cambridge, MA;2010. Available:

Gzil F. Animal models of Alzheimer’s disease and cognitive ageing'. In: First Conference of the European Philosophy of Science Association (Eds. San Pedro I, Solé A.) Madrid. 2007;14-17.

Bensaude-Vincent B, Loeve S, Nordmann A. Matters of interest: the objects of research in science and technoscience. Journal for General Philosophy of Science. 2011;42:365-383. Available: 10.1007/s10838-011-9172-y

Papale A, Cerovic M, Brambilla R. Viral vector approaches to modify gene expression in the brain. Journal of Neuroscience Methods. 2009;15:1-14. Available:

Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nature Reviews. Genetics. 2003;4:346-358. Available: 10.1038/nrg1066

Wirth T, Parker N, Ylä-Herttuala S. History of gene therapy. Gene. 2013;525:162-169. Available:

Weber M. The crux of crucial experiments: Duhem's problems and inference to the best explanation. The British Journal for the Philosophy of Science. 2009;60:19-49. Available: 040

Woodward J. What is a mechanism? A counterfactual account. Philosophy of Science. 2002;69:S366–S377. Available:

Pereira-Leal JB, Levy ED, Teichmann SA. The origins and evolution of functional modules: lessons from protein complexes. Philosophical Transactions of the Royal Society B: Biological Sciences. 2006;361 (1467):507-17. Available:

Psillos S. A glimpse of the secret connexion: Harmonizing mechanisms with counterfactuals. Perspectives on Science. 2004;12:288-319. Available:

Keller EF. Models of and models for: theory and practice in contemporary biology. Philosophy of Science. 2000; 67:72-86. Available:

Thagard P. Pathways to biomedical discovery. Philosophy of Science. 2003; 70:235-241. Available:

Culp S, Kitcher P. Theory structure and theory change in contemporary molecular biology. The British Journal for the Philosophy of Science. 1989;40: 459-483. Available:

Woodward J. What is a mechanism? A counterfactual account. Philosophy of Science.2002;69:S366–S377. Available:

Lee CM, Robinson LJ, Michel T. Oligomerization of endothelial nitric oxide synthase. Evidence for a dominant negative effect of truncation mutants. Journal of Biological Chemistry. 1995;270: 27403-27406. Available:

Kantor DB, Lanzrein M, Stary DJ, Sandoval GM, Smith WB, Sullivan BM, Davidson N, Schuman EM. A role for endothelial NO synthase in LTP revealed by adenovirus-mediated inhibition and rescue. Science. 1996;274:1744-1748. Available:

O'Malley MA, Elliott KC, Burian RM. From genetic to genomic regulation: Iterativity in microRNA research. Studies in History and Philosophy of Biological and Biomedical Sciences. 2010; 41:407–417. Available:

Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature. 2004;431:371-378. Available: 02870